TtRMPVIR Citations (7)
Originally described in: Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi.Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, Lowe SW Nat Biotechnol. 2011 Jan . 29(1):79-83. PubMed Journal
Articles Citing TtRMPVIR
Articles |
---|
Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Zhao Y, Dai Z, Liang Y, Yin M, Ma K, He M, Ouyang H, Teng CB. Sci Rep. 2014 Feb 3;4:3943. doi: 10.1038/srep03943. PubMed |
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells. Rajagopalan KN, Egnatchik RA, Calvaruso MA, Wasti AT, Padanad MS, Boroughs LK, Ko B, Hensley CT, Acar M, Hu Z, Jiang L, Pascual JM, Scaglioni PP, DeBerardinis RJ. Cancer Metab. 2015 Jun 29;3:7. doi: 10.1186/s40170-015-0134-4. eCollection 2015. PubMed |
BET inhibitor resistance emerges from leukaemia stem cells. Fong CY, Gilan O, Lam EY, Rubin AF, Ftouni S, Tyler D, Stanley K, Sinha D, Yeh P, Morison J, Giotopoulos G, Lugo D, Jeffrey P, Lee SC, Carpenter C, Gregory R, Ramsay RG, Lane SW, Abdel-Wahab O, Kouzarides T, Johnstone RW, Dawson SJ, Huntly BJ, Prinjha RK, Papenfuss AT, Dawson MA. Nature. 2015 Sep 24;525(7570):538-42. doi: 10.1038/nature14888. Epub 2015 Sep 14. PubMed |
Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways. Xin B, Yamamoto M, Fujii K, Ooshio T, Chen X, Okada Y, Watanabe K, Miyokawa N, Furukawa H, Nishikawa Y. Oncogene. 2017 Sep 7;36(36):5087-5097. doi: 10.1038/onc.2017.114. Epub 2017 May 8. PubMed |
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses. Timofeev O, Klimovich B, Schneikert J, Wanzel M, Pavlakis E, Noll J, Mutlu S, Elmshauser S, Nist A, Mernberger M, Lamp B, Wenig U, Brobeil A, Gattenlohner S, Kohler K, Stiewe T. EMBO J. 2019 Oct 15;38(20):e102096. doi: 10.15252/embj.2019102096. Epub 2019 Sep 4. PubMed |
The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages. Kisaka JK, Ratner L, Kyei GB. J Virol. 2020 Feb 28;94(6). pii: JVI.01583-19. doi: 10.1128/JVI.01583-19. Print 2020 Feb 28. PubMed |
The levels of reprogramming factors influence the induction and maintenance of pluripotency: the case of CD1 mouse strain cells. Covarrubias L, Martinez-Sarmiento JA, Valencia C, Nagy A, Hernandez-Garcia D. Int J Dev Biol. 2021;65(4-5-6):365-376. doi: 10.1387/ijdb.200233lc. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.